Search results
People With Eating Disorders Are Being Prescribed Ozempic — and the Results Are Dire
PopSugar· 2 days agoThe glucagon-like peptide 1, or GLP-1, drug is a fairly new medication that was originally approved...
Abbott ramps up over-the-counter CGM race with new sensors
MedTech Dive via Yahoo Finance· 3 days agoOne product is the company’s Lingo device, sold as a wellness product for people who do not have ...
Abbott gets FDA clearance for over-the-counter continuous glucose monitors
The Verge· 3 days agoAbbott announced today that the US Food and Drug Administration has cleared two new over-the-counter...
COMMENTARY: Price controls kill more than innovation
Las Vegas Review-Journal· 4 days agoOn average, it takes between 10 and 15 years and $2.6 billion to bring a drug to market. Because of this high cost and
FDA clears Abbott's two new glucose monitors By Investing.com
Investing.com· 3 days agoAbbott has received U.S. Food and Drug Administration (FDA) clearance for its two latest...
Abbott Labs Enters The U.S. Obesity Arena
Investor's Business Daily· 3 days agoThe Food and Drug Administration signed off on Lingo and Libre Rio — vastly expanding Abbott's ...
High price of popular diabetes drugs deprives low-income people of effective treatment
Daily Montanan via Yahoo News· 5 days agoWithout Ozempic or a similar drug, Cooper Harris suffers blackouts, becomes too tired to watch her...
Scams tied to Ozempic and other new weight-loss drugs are surging. How to protect yourself
Los Angeles Times· 24 hours agoOzempic, Wegovy and other new weight-loss drugs have proved so good at helping users shed pounds,...
Scotiabank cuts Biomea Fusion shares target, notes FDA clinical hold concerns By Investing.com
Investing.com· 6 days ago(NASDAQ: BMEA) shares, reducing it to $21.00 from the previous $41.00. The adjustment follows the...
U.S. FDA places clinical hold on Biomea's diabetes trials
Reuters via AOL· 7 days agoThe drug, BMF-219, was being tested in an early-to-mid stage study for type 2 diabetes and a...